We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
-14.57%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$2.28B
AUM Growth
-$525M
Cap. Flow
-$73.7M
Cap. Flow %
-3.24%
Top 10 Hldgs %
24.97%
Holding
2,489
New
246
Increased
163
Reduced
899
Closed
122

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$12.9M
2
AAPL icon
Apple
AAPL
+$4.61M
3
MSFT icon
Microsoft
MSFT
+$3.3M
4
T icon
AT&T
T
+$3.04M
5
CERN
Cerner Corp
CERN
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 21.39%
2 Healthcare 13.76%
3 Financials 11.85%
4 Consumer Discretionary 9.19%
5 Industrials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTS icon
1351
CTS Corp
CTS
$1.82B
$62.6K ﹤0.01%
1,838
-338
-16% -$12.3K
MBUU icon
1352
Malibu Boats
MBUU
$576M
$62.5K ﹤0.01%
1,186
CUBI icon
1353
Customers Bancorp
CUBI
$2.8B
$62.5K ﹤0.01%
1,843
DCOM icon
1354
Dime Commercial Bancshares
DCOM
$1.81B
$62.4K ﹤0.01%
2,105
LZB icon
1355
La-Z-Boy
LZB
$1.64B
$62.3K ﹤0.01%
2,627
BANC icon
1356
Banc of California
BANC
$3.1B
$62.2K ﹤0.01%
3,532
TALO icon
1357
Talos Energy
TALO
$2.59B
$62K ﹤0.01%
4,006
+1,528
+62% +$29.7K
AGYS icon
1358
Agilysys
AGYS
$3.03B
$61.8K ﹤0.01%
1,308
CAL icon
1359
Caleres
CAL
$455M
$61.8K ﹤0.01%
2,355
RVLV icon
1360
Revolve Group
RVLV
$1.69B
$61.7K ﹤0.01%
2,382
NG icon
1361
NovaGold Resources
NG
$3.45B
$61.7K ﹤0.01%
12,828
-2,027
-14% -$12.7K
TBBK icon
1362
The Bancorp
TBBK
$2.83B
$61.7K ﹤0.01%
3,160
BBIO icon
1363
BridgeBio Pharma
BBIO
$15.9B
$61.6K ﹤0.01%
6,788
DLX icon
1364
Deluxe
DLX
$1.09B
$61.5K ﹤0.01%
2,837
WOW
1365
DELISTED
WideOpenWest
WOW
$61.5K ﹤0.01%
3,376
AMWL icon
1366
American Well
AMWL
$215M
$61.5K ﹤0.01%
711
+70
+11% +$5.22K
KYNB
1367
Kyntra Bio
KYNB
$28.7M
$61K ﹤0.01%
231
QVCGA
1368
DELISTED
QVC Group Inc Series A
QVCGA
$61K ﹤0.01%
+425
New +$82.5K
DNUT icon
1369
Krispy Kreme
DNUT
$569M
$60.9K ﹤0.01%
4,480
-1,103
-20% -$15.2K
ANDE icon
1370
Andersons Inc
ANDE
$2.21B
$60.9K ﹤0.01%
1,845
MODN
1371
DELISTED
MODEL N, INC.
MODN
$60.9K ﹤0.01%
2,379
VECO icon
1372
Veeco
VECO
$3.26B
$60.7K ﹤0.01%
3,130
MATW icon
1373
Matthews International
MATW
$725M
$60.6K ﹤0.01%
2,114
GIII icon
1374
G-III Apparel Group
GIII
$1.41B
$60.6K ﹤0.01%
2,994
PACB icon
1375
Pacific Biosciences
PACB
$357M
$60.5K ﹤0.01%
13,679
+1,735
+15% +$10.5K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2022 Portfolio in Review

As of Q2 2022, Metropolitan Life Insurance Company (MetLife) held 2,489 positions worth $2.28B, down 19% from $2.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $73.7M in Q2 2022, closing 122 positions and reducing 899 holdings. Its most notable exit was Cerner Corp, an estimated $1.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Keurig Dr Pepper worth $1.56M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2022 buy was Keurig Dr Pepper: 44,056 shares worth $1.56M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $17.7M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $12.9M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Cerner Corp in Q2 2022, selling an estimated $1.7M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 25% of its $2.28B portfolio in Q2 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 246 new positions and closed 122 in Q2 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 19% quarter-over-quarter to $2.28B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.